We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Investors In Genocea Herpes-Drug Row Get Lead Counsel

Law360 (February 12, 2018, 8:21 PM EST) -- A Massachusetts federal judge on Monday tapped Scott & Scott Attorneys at Law LLP and Levi & Korsinsky LLP to guide investors who have accused Genocea Biosciences Inc. of hiding its inability to finance ongoing trials for a genital herpes immunotherapy and thus blindsiding them when deciding to halt its drug development plans.

Chief U.S. District Judge Patti B. Saris appointed the firms as co-lead counsel while naming a group of five unrelated investors who refer to themselves as the Genocea Investor Group as lead plaintiff...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

Emerson v. Genocea Biosciences, Inc. et al


Case Number

1:17-cv-12137

Court

Massachusetts

Nature of Suit

Securities/Commodities

Judge

Patti B. Saris

Date Filed

October 31, 2017


Case Title

Heaney v. Genocea Biosciences, Inc. et al


Case Number

1:17-cv-12168

Court

Massachusetts

Nature of Suit

Securities/Commodities

Judge

Patti B. Saris

Date Filed

November 3, 2017


Case Title

Walker v. Genocea Biosciences, Inc. et al


Case Number

1:17-cv-12474

Court

Massachusetts

Nature of Suit

Securities/Commodities

Judge

Patti B. Saris

Date Filed

December 15, 2017

Law Firms

Companies

Judge Analytics

Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.